Play Icon




6th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome 2019

Event img
Company image

6th International Conference on Prehypertension, Hypertension, Metabolic Disorders and Cardiovascular Disease, which will take place in Vilnius, Lithuania from 28 February – 3 March, 2019.


Approach to the Elderly with Borderline Metabolic Conditions
Arterial Properties, Central Blood Pressure and Augmentation Index in the Continuum of Prehypertension and Hypertension
Arterial Properties, Evaluation and Treatment in Borderline Conditions
Assessment of Global Cardiovascular Risk Factors in Borderline Conditions
Benefits of Achieving Optimal Risk Factors Level – When, How and with What?
Biomarkers of Borderline Conditions and Preclinical Disease
Borderline Cardiovascular Risk Factors - Morbidity and Mortality
Children and Adolescents and Cardiovascular Risk Factors- Diagnosis, Estimation of Risk and Treatment
Complications of Prehypertension, Hypertension and Cardiometabolic Syndrome: the Heart, the Brain, the Kidney and the Extremities 
Cumulative Effects of Multiple Borderline Cardiometabolic Risk Factors
Diabetes, Prevention, Mechanisms and Treatment of end Organ Damage
Humoral Factors in Prehypertension and Cardiometabolic Syndrome
Hypertension, Mechanisms and Therapeutic Approach
Management of Dyslipidemia, Mechanisms and Novel Therapeutic Regimens 
Metabolic Syndrome and Borderline Metabolic Conditions
Natural History of Prehypertension, Hypertension and End Organ Damage
Obesity, Mechanisms and Therapy
Prediabetes – Mechanism, Diagnosis, and Management
Prehypertension and Metabolic Syndrome in Different Populations – Epidemiology
Prehypertension, Cause and Results
Prehypertension, Prediabetes and Dyslipidemia – Estimation of Risk and Therapeutic Approach
Prehypertension – Progression of Risk and Diagnosis of Disease 
Prehypertension- Mechanism, Diagnosis and Management 
Prevention and Regression of End Organ Damage in Prehypertension 
The Heart, the Brain and the Kidney in Prehypertension and Cardiometabolic Syndrome  
Total Cardiovascular Risk Evaluation and Management

Start date

End date

Company image